Balance, Autonomic Response, and Sensory Modulation to Dosage of Mechanical Vagal Stimulation in Healthy Adults

Last updated: December 2, 2024
Sponsor: University of Vienna
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pain

Neurologic Disorders

Treatment

Sham mechanical Vagus Nerve Stimulation

mechanical Vagus Nerve Stimulation (Intermediate Intensity)

mechanical Vagus Nerve Stimulation (High Intensity)

Clinical Study ID

NCT06541808
EK Nr: 1349/2024
  • Ages 18-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The vagus nerve (VN) plays a crucial role in regulating vital functions (heart rate, blood pressure, digestion, and immune response) and maintaining communication between internal organs and the brain. Recent studies have highlighted the therapeutic potential of VN stimulation (VNS) in treating various conditions such as drug-resistant epilepsy, postural control deficit, COVID-19 infection, chronic pain, and intestinal disorders. In addition, there is growing evidence that the molecules released by the VN neurons affect the function of the gut microbiota and that the molecules released by the bacteria in our gut affect the activity of the VN neurons. In particular, Dr. Giacomo Carta (the leader of this study) has shown how painless neck movements, i.e. mechanical VNS (mVNS), can be applied without adverse effects, representing a potential alternative to invasive methods commonly used today. To further investigate the impact of this novel mVNS, this study aims to evaluate the changes induced by three mVNS protocols on physiological parameters such as resting heart rate, and Heart Rate Variability (HRV) at rest, balance in standing, the perceived intensity of mechanical stimuli using the established clinical method of QST (quantitative sensory testing), fecal transit speed, and the molecular composition of stool (for this, stool samples are analyzed). In particular, stool analysis is very relevant for understanding normal digestion. The present research aims to define the optimal intensity of mVNS and to investigate the therapeutic potential of VNS in the treatment of autonomic dysfunction (such as too low or too high heart rate, too low or too fast digestion, throbbing headaches), as well as falls prevention and pain.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • agreement to participate by signing the informed consent form, being 18-60 yearsold, and sober

Exclusion

Exclusion Criteria:

  • participants having significant neck pain, headache, or leg pain [with Numeric PainRating Scale (NPRS) greater than 3/10],

  • pregnancy

  • recent neck or cardiovascular surgery or significant trauma in the preceding 3months

  • diagnosis of cancer or inflammatory disorders (fever),

  • spinal cord or cauda equina signs,

  • widespread neurological disorders affecting the tone of the limbs and neck muscles

  • underlying diseases, such as diabetes mellitus.

  • pace-maker

  • antibiotic prescription during the last 3 months

  • gastrointestinal surgery,

  • lower extremity injury (acute or overuse) that prevented them from participating insports activities for at least one day in the previous 6 months.

Study Design

Total Participants: 128
Treatment Group(s): 5
Primary Treatment: Sham mechanical Vagus Nerve Stimulation
Phase:
Study Start date:
December 02, 2024
Estimated Completion Date:
September 30, 2025

Study Description

mechanical VNs in humans, induced by a combination of non-painful physiological neck movements, effectively reduces the HR at rest in humans, without any side effects in the short- and long-term. Indeed, HR reduction is a proxy for the VN increased activity among healthy subjects and patients with systemic diseases or autonomic diseases. Mechanical VNs had been successfully adopted in two clinical trials among chronic pain patients (NCT05345496, NCT05360589), but due to the early stage of these new VNs and the clear advantages of this method, studies refining the stimulation protocol are suitable. Thus, the study aims to investigate the possible dose-dependent effects of mVNs on different physiological parameters in humans. 3 protocols of mVNs will be compared consisting of (1) 4 minutes (2 minutes on each side); (2) 12 minutes (3 sessions of 2 minutes of stimulation, with 2 minutes of rest for each side); (3) 16 minutes (8 minutes on each side). The following outcomes will be assessed before and after the stimulation: HR at rest, HRV, balance on standing, perceived intensity and modulation of mechanical stimuli on the skin of the forehead, and the abdomen, gastrointestinal transit, and a fecal sample from the closest intestinal emptying. A total sample of at least 96 healthy subjects (48 females) aged between 18 and 60 are expected to participate. The bidirectional communication between internal organs and the brain via the VN is a well-established scientific fact. Indeed, VNs has beneficial effects on manifold pathological conditions in humans. However, easy-to-apply, non-invasive, and effective VNs methods and standardized protocols are lacking. The here proposed project aims at refining and critically assessing mVNs methods - a prerequisite for exploring the clinical utility of mVNs and fostering its therapeutic potential given the fundamental role of the VN in regulating health and disease. Results obtained from this project will provide data on mVNs on gut microbiota dynamics and the potential benefits for pain modulation, equilibrium impairments, and gastrointestinal dysfunctions.

Connect with a study center

  • UVienna

    Vienna, Wien 1090
    Austria

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.